Fibrogammin 250 I.E.

Fibrogammin 250 I.E. is a medicine authorised by Swissmedic under authorisation number 671. The authorisation holder is CSL Behring AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 October 2003 and the authorisation is valid without a time limit. ATC code B02BD07 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 671
  • ATC B02BD07
  • Blood products
Authorisation data
Authorisation number671
NameFibrogammin 250 I.E.
Full nameFibrogammin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Authorisation holderCSL Behring AG
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeB02BD07
First authorisation13 October 2003
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
3Fibrogammin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB15 February 2007
4Fibrogammin 1'250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB15 February 2007

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
51 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Filter Transfer SetB02BD0706.01.1.B
61 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Filter Transfer SetB02BD0706.01.1.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Fibrogammin 250 I.E. authorised in Switzerland?

Yes. Fibrogammin 250 I.E. is authorised by Swissmedic under authorisation number 671, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fibrogammin 250 I.E. have?

Fibrogammin 250 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fibrogammin 250 I.E.?

The authorisation holder is CSL Behring AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com